Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-769P is a **pseudogene** of the U6 small nuclear RNA gene family, present in the human genome as a non-functional, non-coding sequence[6][7]. U6 snRNA itself is a core catalytic RNA component of the spliceosome, essential for pre-mRNA splicing in the nucleus[3][5]. Pseudogenes such as RNU6-769P closely resemble their functional parental gene (U6 snRNA) but do not encode functional RNA or protein and are generally not transcribed or translated into active molecules[6][8]. Although most pseudogenes are considered non-functional, emerging data suggest some may have subtle regulatory effects at the RNA level, such as acting as microRNA sponges or contributing to transcriptomic diversity; however, there is no current evidence supporting a specific regulatory or disease-related function for RNU6-769P[8][3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 769, pseudogene (RNU6-769P).